Eleven Biotherapeutics Lands $20,000,010 New Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=45d28fee-c244-4e71-8d0b-d34ef78a0e7e - Date
12/8/2014 - Company Name
Eleven Biotherapeutics - Mailing Address
215 First Street Cambridge, MA 02142 USA - Company Description
Eleven Biotherapeutics (NASDAQ: EBIO) uses its proprietary technology platform to create first-of-a-kind protein therapeutics to treat ocular diseases in new and effective ways. - Website
http://www.elevenbio.com - Transaction Type
Venture Equity - Transaction Amount
$20,000,010 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities. - M&A Terms
- Venture Investor
